Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036954
Filing Date
2020-08-05
Accepted
2020-08-05 17:26:43
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 GTHX-Q2-2020 10-Q gthx-10q_20200630.htm   iXBRL 10-Q 1659834
2 EX-10.1 gthx-ex101_371.htm EX-10.1 84928
3 EX-10.2 gthx-ex102_370.htm EX-10.2 330978
4 EX-10.3 gthx-ex103_373.htm EX-10.3 300833
5 EX-31.1 gthx-ex311_315.htm EX-31.1 18795
6 EX-31.2 gthx-ex312_318.htm EX-31.2 18529
7 EX-32.1 gthx-ex321_317.htm EX-32.1 7306
8 EX-32.2 gthx-ex322_316.htm EX-32.2 7286
  Complete submission text file 0001564590-20-036954.txt   6739656

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA gthx-20200630.xsd EX-101.SCH 45543
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20200630_cal.xml EX-101.CAL 31822
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20200630_def.xml EX-101.DEF 113472
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20200630_lab.xml EX-101.LAB 335199
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20200630_pre.xml EX-101.PRE 244779
14 EXTRACTED XBRL INSTANCE DOCUMENT gthx-10q_20200630_htm.xml XML 1026019
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 201078701
SIC: 2834 Pharmaceutical Preparations